Streetbeat News

CBWTF

Auxly Cannabis Group Inc.

https://www.auxly.com/

Industry

Commodity Contracts Dealing

Open

0.03

Mkt cap

45M

Volume

141K

High

0.04

P/E Ratio

-1.17

52-wk high

0.06

Low

0.03

Div yield

N/A

52-wk low

0.01

Marijuana stocks experienced significant movements on February 12, 2024, with Canopy Growth leading the gainers with a 2607.14% increase, while AusCann Group Holdings led the losers with a 44% decrease. Notable companies like Tilray Brands and Cronos Group also saw substantial declines.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

Canada's cannabis vape market is experiencing significant growth, with a 15% year-over-year sales increase in Q4 2023, driven by evolving consumer preferences and regulatory shifts. The report by Zuanic & Associates highlights the market's complexity and the dominance of top players like Auxly, Decibel, and Tilray, which, along with private companies, hold a 53% market share. The popularity of larger 510 cartridge formats and disposables is reshaping the market, with pricing dynamics showing a 9% decrease in the average vape price per gram equivalent. Motif Labs has emerged as a market leader, while Decibel and Tilray face challenges due to slower responses to market trends. Zuanic & Associates maintain Overweight ratings on Decibel and Village Farms, citing their competitive positioning and growth prospects.

Portfolio Pulse from Nicolás Jose Rodriguez

February 07, 2024 | 1:58 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 2, 2024, with notable gainers including Tony G Co-Investment, Global Hemp Group, and Khiron Life Sciences. On the downside, Global Compliance, MJ Holdings, and Rocky Mountain High were among the top losers. Neptune Wellness Solutions, Eastside Distilling, Canopy Growth, cbdMD, Corbus Pharmaceuticals, Tilray Brands, and Cronos Group were notable companies listed on major exchanges that saw price changes.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 1, 2024, with notable gainers including EVIO, Australis Capital, and OrganiGram Holdings, among others. EVIO led with a 9900.00% increase. On the downside, Rhinomed, Khiron Life Sciences, and Item 9 Labs were among the top losers. This reflects a volatile day in the cannabis sector, impacting several US-listed companies such as OrganiGram Holdings (OGI), Psychemedics (PMD), Cronos Group (CRON), Tilray Brands (TLRY), Canopy Growth (CGC), Eastside Distilling (EAST), 22nd Century Group (XXII), Greenlane Holdings (GNLN), SNDL Inc. (SNDL), and Aurora Cannabis (ACB).

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.